Literature DB >> 29049585

Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.

Anne Z Steiner1, David Pritchard2, Frank Z Stanczyk3, James S Kesner4, Juliana W Meadows4, Amy H Herring5, Donna D Baird6.   

Abstract

Importance: Despite lack of evidence of their utility, biomarkers of ovarian reserve are being promoted as potential markers of reproductive potential. Objective: To determine the associations between biomarkers of ovarian reserve and reproductive potential among women of late reproductive age. Design, Setting, and Participants: Prospective time-to-pregnancy cohort study (2008 to date of last follow-up in March 2016) of women (N = 981) aged 30 to 44 years without a history of infertility who had been trying to conceive for 3 months or less, recruited from the community in the Raleigh-Durham, North Carolina, area. Exposures: Early-follicular-phase serum level of antimüllerian hormone (AMH), follicle-stimulating hormone (FSH), and inhibin B and urinary level of FSH. Main Outcomes and Measures: The primary outcomes were the cumulative probability of conception by 6 and 12 cycles of attempt and relative fecundability (probability of conception in a given menstrual cycle). Conception was defined as a positive pregnancy test result.
Results: A total of 750 women (mean age, 33.3 [SD, 3.2] years; 77% white; 36% overweight or obese) provided a blood and urine sample and were included in the analysis. After adjusting for age, body mass index, race, current smoking status, and recent hormonal contraceptive use, women with low AMH values (<0.7 ng/mL [n = 84]) did not have a significantly different predicted probability of conceiving by 6 cycles of attempt (65%; 95% CI, 50%-75%) compared with women (n = 579) with normal values (62%; 95% CI, 57%-66%) or by 12 cycles of attempt (84% [95% CI, 70%-91%] vs 75% [95% CI, 70%-79%], respectively). Women with high serum FSH values (>10 mIU/mL [n = 83]) did not have a significantly different predicted probability of conceiving after 6 cycles of attempt (63%; 95% CI, 50%-73%) compared with women (n = 654) with normal values (62%; 95% CI, 57%-66%) or after 12 cycles of attempt (82% [95% CI, 70%-89%] vs 75% [95% CI, 70%-78%], respectively). Women with high urinary FSH values (>11.5 mIU/mg creatinine [n = 69]) did not have a significantly different predicted probability of conceiving after 6 cycles of attempt (61%; 95% CI, 46%-74%) compared with women (n = 660) with normal values (62%; 95% CI, 58%-66%) or after 12 cycles of attempt (70% [95% CI, 54%-80%] vs 76% [95% CI, 72%-80%], respectively). Inhibin B levels (n = 737) were not associated with the probability of conceiving in a given cycle (hazard ratio per 1-pg/mL increase, 0.999; 95% CI, 0.997-1.001). Conclusions and Relevance: Among women aged 30 to 44 years without a history of infertility who had been trying to conceive for 3 months or less, biomarkers indicating diminished ovarian reserve compared with normal ovarian reserve were not associated with reduced fertility. These findings do not support the use of urinary or blood follicle-stimulating hormone tests or antimüllerian hormone levels to assess natural fertility for women with these characteristics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29049585      PMCID: PMC5744252          DOI: 10.1001/jama.2017.14588

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

1.  Mean Age of Mothers is on the Rise: United States, 2000-2014.

Authors:  T J Mathews; Brady E Hamilton
Journal:  NCHS Data Brief       Date:  2016-01

2.  The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.

Authors:  M Dólleman; M J Faddy; J van Disseldorp; Y T van der Schouw; C M Messow; B Leader; P H M Peeters; A McConnachie; S M Nelson; F J M Broekmans
Journal:  J Clin Endocrinol Metab       Date:  2013-03-18       Impact factor: 5.958

3.  Comparative evaluation of three new commercial immunoassays for anti-Müllerian hormone measurement.

Authors:  H W R Li; B P C Wong; W K Ip; W S B Yeung; P C Ho; E H Y Ng
Journal:  Hum Reprod       Date:  2016-10-04       Impact factor: 6.918

4.  Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years.

Authors:  Anne Z Steiner; Amy H Herring; James S Kesner; Juliana W Meadows; Frank Z Stanczyk; Steven Hoberman; Donna D Baird
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

Review 5.  Mullerian inhibiting substance: a gonadal hormone with multiple functions.

Authors:  M M Lee; P K Donahoe
Journal:  Endocr Rev       Date:  1993-04       Impact factor: 19.871

6.  Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.

Authors:  Cheng-Hsuan Wu; Yu-Ching Chen; Hsin-Hung Wu; Jyuer-Ger Yang; Yu-Jun Chang; Horng-Der Tsai
Journal:  J Assist Reprod Genet       Date:  2009-07       Impact factor: 3.412

7.  Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

Authors:  Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Mark V White; Karen C Schliep; Alan H DeCherney; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2015-09-25       Impact factor: 5.958

8.  A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause.

Authors:  Karl R Hansen; Nicholas S Knowlton; Angela C Thyer; Jay S Charleston; Michael R Soules; Nancy A Klein
Journal:  Hum Reprod       Date:  2008-01-11       Impact factor: 6.918

9.  Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial.

Authors:  Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Karen C Schliep; Rose G Radin; Torie C Plowden; Alan H DeCherney; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2015-12-17       Impact factor: 7.329

Review 10.  The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count.

Authors:  Simone L Broer; Ben Willem J Mol; Dave Hendriks; Frank J M Broekmans
Journal:  Fertil Steril       Date:  2008-03-05       Impact factor: 7.329

View more
  76 in total

1.  Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.

Authors:  Katherine Cameron; Mary D Sammel; Maureen Prewitt; Clarisa Gracia
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence.

Authors:  Edgardo Somigliana; Monica Terenziani; Francesca Filippi; Alice Bergamini; Fabio Martinelli; Giorgia Mangili; Fedro Peccatori; Paolo Vercellini
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

3.  Mitochondrial DNA copy number in peripheral blood: a potential non-invasive biomarker for female subfertility.

Authors:  Andrea Busnelli; Debora Lattuada; Raffaella Rossetti; Alessio Paffoni; Luca Persani; Luigi Fedele; Edgardo Somigliana
Journal:  J Assist Reprod Genet       Date:  2018-08-17       Impact factor: 3.412

4.  Perceived infertility and contraceptive use in the female, reproductive-age cancer survivor.

Authors:  Tracy N Hadnott; Shaylyn S Stark; Alexa Medica; Andrew C Dietz; Maria Elena Martinez; Brian W Whitcomb; H Irene Su
Journal:  Fertil Steril       Date:  2019-04       Impact factor: 7.329

Review 5.  Emerging roles for noncoding RNAs in female sex steroids and reproductive disease.

Authors:  Runju Zhang; Victoria Wesevich; Zhaojuan Chen; Dan Zhang; Amanda N Kallen
Journal:  Mol Cell Endocrinol       Date:  2020-07-12       Impact factor: 4.102

6.  Anti-Müllerian hormone levels in nurses working night shifts.

Authors:  Candice Y Johnson; Lauren J Tanz; Christina C Lawson; Penelope P Howards; Elizabeth R Bertone-Johnson; A Heather Eliassen; Eva S Schernhammer; Janet W Rich-Edwards
Journal:  Arch Environ Occup Health       Date:  2019-04-04       Impact factor: 1.663

7.  Menstrual Cycle Characteristics in Adolescence and Early Adulthood Are Associated With Risk of Early Natural Menopause.

Authors:  Brian W Whitcomb; Alexandra Purdue-Smithe; Susan E Hankinson; JoAnn E Manson; Bernard A Rosner; Elizabeth R Bertone-Johnson
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

8.  Modeling Variation in the Reproductive Lifespan of Female Adolescent and Young Adult Cancer Survivors Using AMH.

Authors:  H Irene Su; Brian Kwan; Brian W Whitcomb; Ksenya Shliakhsitsava; Andrew C Dietz; Shaylyn S Stark; Elena Martinez; Patrick M Sluss; Mary D Sammel; Loki Natarajan
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

9.  The effect of endometriosis on the antimüllerian hormone level in the infertile population.

Authors:  Phillip A Romanski; Paula C Brady; Leslie V Farland; Ann M Thomas; Mark D Hornstein
Journal:  J Assist Reprod Genet       Date:  2019-04-16       Impact factor: 3.412

10.  One-year impact of bariatric surgery on serum anti-Mullerian-hormone levels in severely obese women.

Authors:  Clara Vincentelli; Marie Maraninchi; René Valéro; Sophie Béliard; Flavia Maurice; Olivier Emungania; Bruno Berthet; Elise Lombard; Anne Dutour; Bénédicte Gaborit; Blandine Courbiere
Journal:  J Assist Reprod Genet       Date:  2018-05-12       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.